1. Home
  2. BOLD vs NTZ Comparison

BOLD vs NTZ Comparison

Compare BOLD & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • NTZ
  • Stock Information
  • Founded
  • BOLD 2018
  • NTZ 1959
  • Country
  • BOLD United States
  • NTZ Italy
  • Employees
  • BOLD N/A
  • NTZ N/A
  • Industry
  • BOLD
  • NTZ Home Furnishings
  • Sector
  • BOLD
  • NTZ Consumer Discretionary
  • Exchange
  • BOLD Nasdaq
  • NTZ Nasdaq
  • Market Cap
  • BOLD 30.3M
  • NTZ 49.5M
  • IPO Year
  • BOLD 2024
  • NTZ 1993
  • Fundamental
  • Price
  • BOLD $1.50
  • NTZ $3.69
  • Analyst Decision
  • BOLD Hold
  • NTZ
  • Analyst Count
  • BOLD 1
  • NTZ 0
  • Target Price
  • BOLD N/A
  • NTZ N/A
  • AVG Volume (30 Days)
  • BOLD 63.1K
  • NTZ 5.3K
  • Earning Date
  • BOLD 05-16-2025
  • NTZ 06-20-2025
  • Dividend Yield
  • BOLD N/A
  • NTZ N/A
  • EPS Growth
  • BOLD N/A
  • NTZ N/A
  • EPS
  • BOLD N/A
  • NTZ N/A
  • Revenue
  • BOLD N/A
  • NTZ $330,051,765.00
  • Revenue This Year
  • BOLD N/A
  • NTZ N/A
  • Revenue Next Year
  • BOLD N/A
  • NTZ N/A
  • P/E Ratio
  • BOLD N/A
  • NTZ N/A
  • Revenue Growth
  • BOLD N/A
  • NTZ N/A
  • 52 Week Low
  • BOLD $1.06
  • NTZ $3.72
  • 52 Week High
  • BOLD $12.26
  • NTZ $6.27
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • NTZ 36.36
  • Support Level
  • BOLD N/A
  • NTZ $3.64
  • Resistance Level
  • BOLD N/A
  • NTZ $5.00
  • Average True Range (ATR)
  • BOLD 0.00
  • NTZ 0.32
  • MACD
  • BOLD 0.00
  • NTZ -0.03
  • Stochastic Oscillator
  • BOLD 0.00
  • NTZ 3.68

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio including sofas, loveseats, armchairs, sectional furniture, motion furniture and sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private label, and Natuzzi Editions. Geographically, it derives a majority of revenue from the United States of America and also has an international presence in Italy, Spain, UK and Other countries.

Share on Social Networks: